Maat Pharma SA (MAAT) - Cash Flow Conversion Efficiency

Latest as of June 2025: -1.853x

Based on the latest financial reports, Maat Pharma SA (MAAT) has a cash flow conversion efficiency ratio of -1.853x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-15.37 Million ≈ $-17.97 Million USD) by net assets (€8.29 Million ≈ $9.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Maat Pharma SA - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Maat Pharma SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Maat Pharma SA carry for a breakdown of total debt and financial obligations.

Maat Pharma SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Maat Pharma SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Pelthos Therapeutics Inc. NYSE MKT:PTHS	-0.161x
Sypris Solutions Inc NASDAQ:SYPR	-0.009x
Vow ASA OL:VOW	0.004x
Panelsan Cati Cephe Sistemleri Sanayi ve Ticaret AS IS:PNLSN	0.023x
Aldoro Resources Ltd AU:ARN	-0.048x
Shandong Zhonglu Oceanic Fisheries Co Ltd SHE:200992	-0.021x
Mitchell Services Ltd AU:MSV	0.121x
Hwacheon Machi KO:010660	-0.024x

Annual Cash Flow Conversion Efficiency for Maat Pharma SA (2017–2024)

The table below shows the annual cash flow conversion efficiency of Maat Pharma SA from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see Maat Pharma SA (MAAT) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€10.34 Million ≈ $12.08 Million	€-22.04 Million ≈ $-25.77 Million	-2.132x	-133.76%
2023-12-31	€20.47 Million ≈ $23.93 Million	€-18.67 Million ≈ $-21.83 Million	-0.912x	-94.04%
2022-12-31	€26.81 Million ≈ $31.34 Million	€-12.61 Million ≈ $-14.74 Million	-0.470x	-136.32%
2021-12-31	€39.86 Million ≈ $46.60 Million	€-7.93 Million ≈ $-9.27 Million	-0.199x	+45.47%
2020-12-31	€15.94 Million ≈ $18.63 Million	€-5.81 Million ≈ $-6.80 Million	-0.365x	-133.18%
2019-12-31	€-4.57 Million ≈ $-5.34 Million	€-5.02 Million ≈ $-5.87 Million	1.099x	+136.04%
2018-12-31	€1.27 Million ≈ $1.48 Million	€-3.87 Million ≈ $-4.53 Million	-3.050x	-315.12%
2017-12-31	€5.27 Million ≈ $6.16 Million	€-3.87 Million ≈ $-4.53 Million	-0.735x	--

About Maat Pharma SA

PA:MAAT France Biotechnology

Market Cap

$128.25 Million

€109.70 Million EUR

Market Cap Rank

#20262 Global

#315 in France

Share Price

€5.85

Change (1 day)

+1.04%

52-Week Range

€3.65 - €7.78

All Time High

€13.95